Suntec Medical
Pharmaceutical company focused on drug development and clinical trials.
About
Suntec Medical is a pharmaceutical company that is actively seeking funding to accelerate the clinical trials of its four drug candidates. The company is planning a Nasdaq IPO in Q2 2027 and is currently in discussions for a $25 million Series A private placement.
Similar companies
Cloud-based platform for clinical trial data management and analytics.
Shares Pharmaceuticals
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Biotechnology company focused on developing cancer immunotherapies.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Key facts
- Headquarters
- Taipei, Taiwan
- Total funding
- $25M (Series A)
- Business model
- B2B
Frequently asked
How much funding has Suntec Medical raised?
Suntec Medical has raised a total of $25M in funding. The most recent round on record is Series A.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Suntec Medical
